THERAPEUTIC EMBOLISATION

This adverse event was reported 312 times

These drugs are most commonly taken by patients reporting THERAPEUTIC EMBOLISATION:

# Drug Count
0 FUROSEMIDE 34
1 SILDENAFIL CITRATE 22
2 TELOTRISTAT ETHYL 22
3 APIXABAN 21
4 SPIRONOLACTONE 21
5 BOSENTAN 20
6 OCTREOTIDE ACETATE 20
7 SOFOSBUVIR 20
8 PREDNISONE 19
9 ASPIRIN 14
See all common drugs associated with THERAPEUTIC EMBOLISATION

THERAPEUTIC EMBOLISATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NEFAZODONE HYDROCHLORIDE 1 0.0083
1 CEFTAZIDIME, AVIBACTAM 1 0.0059
2 STREPTOZOCIN 1 0.0043
3 TELOTRISTAT ETHYL 22 0.0038
4 DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG 2 0.0024
5 METYRAPONE 2 0.0020
6 TEBENTAFUSP 1 0.0017
7 BEVACIZUMAB-BVZR 1 0.0014
8 LIDOCAINE AND PRILOCAINE 2 0.0014
9 CARBOPROST TROMETHAMINE 1 0.0014
See all drugs enriched for association with THERAPEUTIC EMBOLISATION